Home/Filings/4/0001209191-22-047067
4//SEC Filing

Hillan Kenneth J. 4

Accession 0001209191-22-047067

CIK 0001804591other

Filed

Aug 21, 8:00 PM ET

Accepted

Aug 22, 6:12 PM ET

Size

5.1 KB

Accession

0001209191-22-047067

Insider Transaction Report

Form 4
Period: 2022-08-20
Hillan Kenneth
Head of Therapeutics
Transactions
  • Tax Payment

    Class A Common Stock

    2022-08-20$3.33/sh4,628$15,411204,836 total
Footnotes (1)
  • [F1]The closing price on August 19, 2022, the fair market used for the transaction date.

Issuer

23andMe Holding Co.

CIK 0001804591

Entity typeother

Related Parties

1
  • filerCIK 0001600359

Filing Metadata

Form type
4
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 6:12 PM ET
Size
5.1 KB